| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.082 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.14 | 0.7 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |